The 10-second takeaway
For the quarter ended March 31 (Q1), Amphenol met expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share increased. GAAP earnings per share grew significantly.
Gross margins shrank, operating margins increased, net margins expanded.
Amphenol logged revenue of $1.08 billion. The 11 analysts polled by S&P Capital IQ foresaw revenue of $1.07 billion on the same basis. GAAP reported sales were 10% higher than the prior-year quarter's $981.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.87. The 13 earnings estimates compiled by S&P Capital IQ averaged $0.86 per share. Non-GAAP EPS of $0.87 for Q1 were 13% higher than the prior-year quarter's $0.77 per share. GAAP EPS of $0.94 for Q1 were 22% higher than the prior-year quarter's $0.77 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 31.3%, 20 basis points worse than the prior-year quarter. Operating margin was 19.2%, 30 basis points better than the prior-year quarter. Net margin was 14.2%, 130 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $1.13 billion. On the bottom line, the average EPS estimate is $0.94.
Next year's average estimate for revenue is $4.63 billion. The average EPS estimate is $3.84.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Amphenol is outperform, with an average price target of $72.64.
Looking for alternatives to Amphenol? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Amphenol to My Watchlist.